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When meperidine (Demerol) was shown to possess marked analgesic 
properties (Eisleb and Schaumann, 1939) and thus became the first potent 
synthetic analgesic drug, the importance of the 1,4-substituted piperidine 
nucleus in providing analgesic activity became apparent. Many modifica- 
tions of this basic chemical structure have been synthesized and studied 
pharmacologically in an attempt to achieve greater analgesic potency. 
Two such derivatives, synthesized by Elpern e$ uZ. (1959), showing anal- 
gesic activity greater than meperidine are piminodine (Win 14,098-2, 
ethyl 4-phenyl-l- [ 3- (phenylamino)propyl] piperidine-4-carboxylate) and 
Win 13,797 (ethyl 4-phenyl-l-[ 2-(phenylamino)ethyl]piperidine-4-car- 
boxylate). 
Pharmacologic studies of these two derivatives in comparison with 
meperidine and morphine are presented in this report. 
METHODS 
Unless otherwise indicated, aqueous solutions were administered by 
the routes indicated and piminodine and Win 13,797 were administered 
as the ethane sulfonate salts. Morphine and meperidine were injected as 
the sulfate and hydrochloride salts, respectively. 
1 Alvodine, trademark, Winthrop Laboratories, New York. 
2 These studies were supported in part by a grant from the Sterling-Winthrop 
Research Institute. 
3 Present address: Department of Pharmacology, State University of Iowa, Iowa 
City, Iowa. 
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Toxicity 
The subcutaneous LDbO in mice was determined from studies with at 
least 5 doses and a minimum total number of 100 animals. 
Dogs were given doses of 1.3-39 mg,/kg intravenously, the highest 
dosage being lethal. No attempt was made to obtain a precise LD5,, value 
for this species. 
Nontolerant rhesus monkeys were injected with increasing amounts 
(no more than one dose in a given animal) of piminodine and Win 13,797 
until doses were determined which produced definite depression, but not 
death. Two animals were injected with each dose of each drug. The 
psychic depression (stupor) and motor depression (muscular weakness) 
which resulted from effective doses of these drugs were graded on an 
8-grade scale according to the method of Irwin (1954). Respiratory 
depression produced by the drugs was graded on the scale of mild, inter- 
mediate, severe, and very severe. 
Analgesia 
Two animal experimental methods were utilized for the assay of 
analgesia. The first was the hot-plate procedure described by Eddy and 
Leimbach (1953) using male mice. Each drug was administered subcu- 
taneously in at least 5 doses to a minimum total number of 100 animals. 
The second procedure for analgesic testing was the Robbins (1955) 
modification of the hot-wire technique described by Davies ,et a,!. (1946) 
for use on rats. At least 70 animals were used for each drug administered 
subcutaneously in at least 5 doses. 
All results were analyzed statistically according to the method of 
Litchfield and Wilcoxon ( 1949). 
Cardiovascular Actions 
Acute vascular tolerance-crossed tolerance to morphine. These ex- 
periments were performed on 42 mongrel dogs weighing 8-20 kg and 
anesthetized with pentobarbital. All injections were made intravenously; 
blood pressure was recorded from a mercury manometer. Respiratory 
activity was recorded via a tambour attached to a pneumograph placed 
low on the thorax. Some animals were allowed to breathe spontaneously 
and others were respired mechanically. 
Perfusion of the hind limb 0) the dog. The method utilized was that 
described by Beck (1958). All compounds were initially dissolved in 
propylene glycol, and then diluted with saline or water as indicated. 
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PapiZlary muscle. The papillary muscle preparation of Cattell and 
Gold (1938), as modified by Bennett (19.58), was employed. All muscles 
were subjected to 2.0 .g tension. 
Dog heart-lung preparation. A modified heart-lung preparation of 
Knowlton and Starling (1912) was used. Alteration of cardiac function 
in this preparation was determined by the Competence Index method of 
Wollenberger (1947), as well as by the Slope method of Price and 
Helrich (1955). 
GastrointestinaZ Action-Isolated Rabbit Jejunal Segment 
Rabbits were killed by a blow on the head, and the jejunum was 
removed promptly, placed in Tyrode’s solution, and cut into approximately 
equal l-inch segments. Each segment was suspended in Tyrode’s solu- 
tion which was aerated and maintained at a temperature of 37.5’ C. 
Activity was recorded via an isotonic muscle lever and kymograph system. 
Newopharmacologic Studies 
Six beagle dogs were prepared with chronically implanted electrodes 
according to the method of Domino and Ueki (1959). Bipolar stainless 
steel electrodes were placed epidurally and/or subdurally in various por- 
tions of the cerebral cortex including areas 8, 6, 4, 1, 2, 5, and 17. Sub- 
cortical electrodes were placed usually in the mesencephalic reticular for- 
mation, dorsal or posterior hypothalamus, and portions of the limbic 
system including the olfactory bulb and medial amygdala. At least 
1 month elapsed from the time of the surgical implantation until drug 
testing. All animals were free of nemologic deficit and had normal elec- 
troencephalograms (EEG) . A Grass model III g-channel electroencephalo- 
graph was used for electrical recording. The effects of various narcotics 
were determined in unanesthetized, partially restrained dogs viewed 
through a window with one-way vision, Thoracic respiration was recorded 
qualitatively with a rubber bellows connected to a Statham pressure trans- 
ducer and was recorded on one channel of the electroencephalograph. All 
sites of electrode placement were verified histologically by the Hess 
method of iron deposition, staining for the Prussian blue and green color 
reaction, and counterstaining with thionin. 
The effects of I mg/kg of piminodine, Win 13,797, and morphine sulfate 
given intravenously were compared in six dogs. Each agent was ad- 
ministered randomly in a crossover design to the various animals. The 
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dogs received only one narcotic per week. After the peak of drug effect, 
nalorphine hydrochloride was given intravenously in a dose of I mg/kg. 
Toleranc8e and Addiction 
Monkey. (a). Single-dose suppression. The drugs were evaluated to 
determine if they had the capacity specifically to suppress morphine ab- 
stinence signs. Monkeys which were physically dependent on morphine 
sulfate (3 mg/kg subcutaneously every 6 hours) were withdrawn until 
abstinence signs of intermediate severity were present ( 12-14 hours). 
Placebo (saline) ; morphine sulfate, 3 mg/kg; piminodine, 0.1, 0.2, and 
0.4mg/kg; and Win 13,797, 0.05, 0.1, and 0.2 mg/kg, were each 
administered to 5 randomly selected monkeys. An observer who was 
unaware of the nature of the treatments established an effect-dura- 
tion curve for each monkey by grading abstinence signs and/or drug 
depression below normal excitability by the methods of Irwin (1954). 
The monkeys were graded just prior to injection of the test drug and at 
intervals of s, I, 2, 3, 4, etc., hours after injection until each monkey 
returned to its preinjection level of excitability. 
(b). Primary physical dependence and tolerance. Win 13,797 was 
administered chronically every 6 hours to a group of 3 monkeys to de- 
termine whether the drug would produce physical dependence directly. 
The monkeys had not previously received any narcotic drugs. The dose 
was increased as tolerance development to the general depressant and 
anorexic effects permitted. The drug was administered according to the 
following dosage schedule: days l-7 (0.1 mg/kg) ; 8-20 (0.2 mg/kg) ; 
21-29 (0.4 mg/kg) ; 30-62 (0.8 mg/kg) ; 63-98 ( 1.2 mg/kg) ; 99-109 
(2.Omg/kg); and 110-146 (3.Omg/kg). 
Dog-Primary Physical Dependence 
Primary physical dependence studies with piminodine, Win 13,797, 
and morphine were also conducted in the dogs. Although the dog is 
ordinarily less well suited to such studies than the monkey, it appears to 
resemble man more closely than does the monkey with respect to its 
relative sensitivity to synthetic piperidine derivatives. Each drug was 
administered subcutaneously every 6 hours to a group of 5 dogs in the 
following doses: for piminodine, days l-4 (1.0 mg/kg), S-26 (2 mg/kg), 
27-45 (4.0 mg/kg), and 46-49 (6.0 mg/kg) ; for morphine sulfate and 
Win 13,797, days l-26 (l.Omg/kg), 27-45 (2.Omg/kg), and 46-49 
(3.0 mg/kg) . Each increase in dosage produced anorexia which resulted 
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in loss of body weight. The dosage was increased after tolerance to the 
anorexia had developed and lost body weight had been regained. 
Withdrawals were precipitated on the 26th, 45th, and 65th days by 
the subcutaneous administration of 2 mg/kg of nalorphine, and all drugs 
were abruptly withdrawn on the 69th day. 
Distribution and Excretion in Dogs and Monkeys 
Specific procedures were developed for the microestimation of pimino- 
dine and Win 13,797 to levels of 0.1 pg/ml of plasma or urine or 0.5 pg/g 
of tissue by a modification of the methyl orange technique of Brodie and 
Udenfriend (1945). These procedures were shown to be specific by 
comparison of known drugs and unknown drugs extracted from urine and 
compared in buffer distribution studies. 
Estimation of pim&odi%e. To a 35ml glass-stoppered, centrifuge tube 
were added successively (a) 5 ml water solution of drug, or urine, or 
plasma, or tissue homogenate; (b) 15 ml (purified as described by Woods 
et aZ., 1951) ethylene dichloride (EtCls) ; and (c) 3 ml of 0.5 M, pH 7.5, 
phosphate buffer. The sample was shaken 30 minutes in an International 
Shaker Machine at a frequency of about 280 oscillations per minute in 
tube holders as described previously (Woods et aZ., 1951) and was cen- 
trifuged 4 minutes; the aqueous (upper) layer was then removed with a 
clean glass tip connected with a water aspirator. The EtClz was shaken 
twice with 5 ml of 0.2 N NaOH and once with 5 ml of 0.25 M, pH 5.1, 
phosphate buffer. Each time the mixture was shaken 1 minute by hand, 
then centrifuged 4 minutes, and the aqueous (upper) layer was removed 
as above. An aliquot of 13 ml of the EtClz layer was transferred to a clean 
centrifuge tube, 5 ml of 0.5 N HCI was added, and the mixture was 
shaken for 10 minutes. The mixture was centrifuged 4 minutes and the 
Et(& (lower) layer was removed with a cZean aspirating tube. An aliquot 
of 4.5 ml of the acid solution was transferred to a clean centrifuge tube, 
10 ml of pure Et& and 1 ml of 2.5 N NaOH were added, and the 
samples were shaken mechanically for 30 minutes. The mixture was cen- 
trifuged 4 minutes, then the water layer was removed. The EtClz layer 
was shaken 1 minute by hand with 5 ml of 1 M, pH 8.6, phosphate buffer 
as noted above and centrifuged 4 minutes; then the aqueous layer (upper) 
was removed. 
Nine milliliters of the EtClz was pipetted into a clean centrifuge tube, 
and 0.5 ml of methyl orange reagent4 (prepared by dilution of some of 
4 Prepared as described by Woods et UL (1953). 
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the stock solution with an equal volume of I It4 boric acid). The mixture 
was shaken 10 minutes and centrifuged 4 minutes; most of the methyl 
orange reagent was removed by aspiration without loss oj EtCl$. As 
much of the EtClz as possible was transferred without any aqueous dye 
solution, into a clean centrifuge tube. To reduce the blank values, the 
organic solvent was shaken 1 minute with 3 ml of diluted methyl orange 
reagent (1.6 ml stock solution diluted to 200 ml with 1 II4 boric acid) 
and centrifuged 4 minutes; the aqueous methyl orange Iayer was removed 
by aspiration. Seven milliliters of the above EtClz containing the methyl 
orange complex of the drug was pipetted into a clean centrifuge tube, 
1 ml of 2 N HCI was added, and the mixture was shaken mechanically 
for IO minutes and centrifuged 4 minutes; the EtClz layer (lower) re- 
moved carefully by aspiration without loss of aqueous solution. Most of 
the colored acid solution was transferred with a l-ml pipette to a micro- 
cell and read at 515 mu in the Beckman DU spectrophotometer. 
Duplicate determinations on known standards, having a concentration 
in the range of the unknown samples, were carried through the procedure 
with each set of unknowns. 
The recovery of known amounts of piminodine was about 110 ? 20 
(S.D.) % for the range of 0.1-2.0 ug/ml added to plasma or urine, or 
above 0.5 pg/g added to tissue. 
Estimution of W~PZ 13,797. To a 35ml glass-stoppered centrifuge tube 
were added successively (a) 5 ml of water solution of drug, plasma, urine, 
or tissue homogenate; (b) 1.5 ml of EtClz; and (c) 3 ml of 0.5 J4 pH 7.5, 
phosphate buffer. The same was shaken mechanically for 30 minutes at 
a rate of 280 oscillations per minute. The mixture was then centrifuged 
for 4 minutes as described previously, and the aqueous layer (upper) was 
removed by aspiration. The EtClz was washed once by shaking 1 minute 
by hand with 5 ml of the following: twice with 0.2 N NaOH, once with 
0.025 N, pH 5.1, phosphate buffer, and once with 0.1 N HCl.5 The 
manipulations of centrifugation and aspiration of the aqueous layer were 
performed after each wash. The EtClz was shaken mechanically with 5 ml 
of 0.1 N HCl for 10 minutes and centrifuged; the acid layer was removed 
by aspiration. An aliquot of 13 ml of the EtClz was transferred to a clean 
centrifuge tube and shaken with the methyl orange reagent as described 
for piminodine except that 10 ml of the EtC12 was transferred for the 
final extraction of the dye into 1 ml of 2.0 N HCl. 
5 Under these conditions the amine is not extracted into the aqueous acid phase, 
thus indicating the very weak basic nature of the Win 13,797. 
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The recovery of known amounts of Win 13,797 was about 108 * 18 
(SD.) % for the range of 0.1-2.0 pg/ml added to plasma or urine, or 
above 0.5 pg/g added to tissue. 
Preparation oj tissues. Three grams of tissue (it may be necessary to 
mince some tissues before they can be homogenized easily) was homog- 
enized in 12.0 ml of OS M, pH 7.5, phosphate buffer with the glass tube 
cooled in an ice bath. Two S-ml portions of the homogenate were pipetted 
into two clean centrifuge tubes and analyzed in duplicate according to the 
procedures noted above. 
The following tissues and body fluid were analyzed: brain, lungs, 
kidney, liver, spleen, skeletal muscle, cardiac muscle, fat (omental), low 
duodenum, and gall bladder bile. 
RESULTS AND DISCUSSION 
Toxicity 
The LD5” values of piminodine and Win 13,797 in mice in comparison 
with morphine are given in Table 1. The animals usually died after 
convulsions. 
TABLE I 
COMPARISON OF LETHAL AND ANALGESIC POTENCY OF PIMINODINE, WIN 13,797, 





LDso, w/k ADeo, w/W 
(19/20 confidence (19/20 confidence 
limits) limits) 
228 (218-234) 1.34 (0.99-1.81) 
175 (165-181) 0.86 (0.78-0.95) 
41.2 (301-561) 4.4 (3.9 -4.9 ) 
IZ These values were ohtained with the hot-plate method for testing analgesia. 
The intravenous administration of piminodine or Win 13,797 to dogs 
(total of 8 dogs and 11 dogs, respectively, for each drug) gave the fol- 
lowing results: 
1. After doses of 1.3, 3.2, and 6.5 mg/kg, neither drug produced im- 
mediate excitement and disorientation as observed after the intravenous 
injection of comparable doses of morphine. However, typical sedation, 
narcosis, and the hyenoid gait resulted, the latter being less pronounced 
than that seen after morphine. In identical dosage, Win 13,797 produced 
more profound narcosis lasting for a longer period than that observed 
with piminodine. The intravenous injection of nalorphine hydrochloride 
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(3 mg/kg) immediately antagonized the depressant effects of both drugs. 
Salivation occurred after the administration of each drug, but emesis 
was not produced in any animal by either drug. 
2. After doses of 13 mg/kg, both drugs produced tremors or mild con- 
vulsions within a very few minutes. The stimulation was followed by a 
long period of depression, but with survival of the animals. 
3. After doses of 26, 32, and 39 mg/kg (1 dog after each drug at each 
dosage), both drugs produced almost immediate convulsions, principally 
of the grand ma1 type. The dogs survived from doses of 26 and 32 mg/kg 
but died after 39 mg/kg. The one dog given the latter dose of Win 13,797 
died in 30 minutes, and that given piminodine died in .S minutes. It was 
quite evident that with the higher doses (13, 26, 32, and 39 mg/kg) 
piminodine exhibited a more pronounced stimulant action on the central 
nervous system than Win 13,797. 
The subcutaneous injection of 0.1 mg/kg of piminodine and 0.5 mg/kg 
of Win 13,797 to nontolerant monkeys produced sedation, slight ataxia, 
and slight respiratory depression. The administration of double the 
above doses of each drug resulted in more marked depression (moderate 
stupor grade 4 depression) of the central nervous system, slight ataxia, 
and more marked depression of respiration. Thus, Win 13,797 is about 
twice as potent as piminodine as a depressant of the monkey. The monkey 
is very sensitive to these agents as compared with the dog or man. 
Analgesia 
The analgesic potencies of piminodine and Win 13,797 are compared 
with morphine in the mouse and the rat in Tables 1 and 2. Both pimin- 
odine and Win 13,797 are more potent than morphine. 
TABLE 2 
COMPARISON OF THE ANALGESIC POTENCY OF PLVXINODINE, WIN 13,797, AND MORPHINE 
AFTER SUBUJTANE~US INJECTION IN RATS AS MEASURED my THE HOT-WIRE TAIL-FLICK 
METHOD 
Piminodine Win 13,797 Morphine 
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AC&e vascular tolerance in pentobarbitalized dogs-crossed tolerance 
to morp&e. (a). Spontaneous respiration. The initial intravenous injec- 
tion of 1.3 mg/kg ( 1.0 mg/kg as free base) uniformly reduced the blood 
pressure to a moderate level (viz., to about 90-100 mm of mercury) 
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FIG. I. Typical results after repeated intravenous injection of 1.3 mg/kg of 
piminodine and Win 13,797 (the l.O-mg/kg values are free base) followed by 1.3 
mg/kg of morphine sulfate (1.0 mg/kg as free base) as compared with the effect of 
a single injection (no prior treatment with narcotic agent) of morphine (block 
on the right). Ah animals respired spontaneously; the interval between injections 
was 15 minutes. Time in minutes is plotted along the abscissa, and blood pressure in 
millimeters of mercury along the ordinate. 
(Fig. 1) which persisted throughout the experiment. Subsequent injec- 
tions at 15minute intervals of 1.3 mg/kg ( 1.0 mg/kg as free base) of 
either piminodine or Win 13,797 did not result in an additional significant 
reduction in blood pressure. Morphine sulfate in identical initial dosage 
(no drug having been administered previously) produced a more profound 
hypotension (Fig. 1) . 
In some animals the intravenous injection of 2.6 mg/kg (2 mg/kg as 
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free base) of either drug produced respiratory depression followed in 
2-3 minutes by vascular collapse and death in approximately one-half of 
the animals. The intravenous administration of 5.2 mg/kg (4 mg/kg as 
free base) of either drug produced the above respiratory depression fol- 
lowed by death in nearly every animal (Fig. 2B). The intravenous ad- 
ministration of nalorphine hydrochloride (3 mg/kg) antagonized these 
respiratory depressant effects of piminodine and Win 13,797. 
The administration of three or four consecutive doses of 1.3 mg/kg 
(1.0 mg/kg as free base) of either drug by the intravenous route showed 
partial or complete vascular tolerance to this dose. Such animals showed 
a reduced hypotensive effect (crossed tolerance) of 1.3 mg/kg ( 1.0 mg/kg 
as free base) of morphine administered intravenously. 
(b). Artificial respiration. Since the above results indicated that death 
with doses of 2.6-5.2 mg/kg of piminodine and Win 13,797 was primarily 
due to respiratory depression, the effect of artificial respiration was studied. 
Doses of 5.2 mg/kg of either drug administered intravenously (i.v.) to 
dogs anesthetized with pentobarbital and respired mechanically produced 
hypotension more pronounced than that following the administration of 
doses of 1.3 mg/kg, but generally less than that produced by 1.3 mg/kg 
of morphine sulfate. In such animals the repeated administration of the 
large doses (5.2 mg/kg; 4 mg/kg as free base) demonstrated the develop- 
ment of acute vascular tolerance and partial cross tolerance to morphine 
(Fig. 2). Cardiovascular function remained adequate as long as sufficient 
respiratory exchange was provided. 
Dog hitid-limb perfusion. Piminodine and Win 13,797 were equipotent 
in producing vasodilation in the femoral vascular bed of the dog, whether 
administered i.a. or i.v. A total dose of 0.1 mg of either compound, 
injected i.a., caused a 30% decrease in limb peripheral resistance which 
returned to control values within 2 minutes. A dose of 0.5 mg/kg of 
either compound, injected i.v., produced a slight transient fall in mean 
systemic blood pressure, not more than 10 mm Hg, which was associated 
with an initial slight transient reflex increase in limb perfusion pressure. 
After this, as the drug reached the hind limb after passage through the 
pump system, a 30-407~ decrease in limb perfusion pressure was observed 
which returned to normal within 15 minutes. 
Studies employing this technique would suggest that there appears to 
be no acute centrally mediated vasodilatation with the doses employed 
in this part of the study. The hypotensive effect of piminodine and 
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Win 13,797 can be explained, in part at least, by direct peripheral 
vasodilatation of vascular areas similar to the femoral bed. 
Papillary muscle and dog heart-lung preparations. Approximately a 
10% depression of contractility of the eudynamic cat papillary muscle 
was noted after 30 minutes’ exposure to a concentration of 1.0 m&l 
B. SPONTANEOUS 
A. ARTIFICIAL RESPIRATION RESPIRATION 
TIME IN MiNUTES 
,a-? 2 ‘? 15 
‘I 
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FIG. 2. Comparison of the effect of the intravenous injection of 2.6-5.2 mg/kg 
(2-4 mg/kg as free base) of piminodine and Win L3,797 in dogs on artificial respira- 
tion (A) and dogs respiring spontaneously (B). Where applicable the interval be- 
tween injections was IS minutes. Time in minutes is plotted along the abscissa and 
blood pressure in millimeters of mercury along the ordinate. 
piminodine in Ringer’s solution, whereas approximately 50% depression 
was obtained after 30 minutes’ exposure to a concentration of 10 mg/l. 
This depression could not be attributed to pH changes of the bathing 
solution as a result of drug administration. No potentiation of barbitu- 
rate-induced myocardial depression was observed with either agent. The 
depression produced by these agents at 10 mg/l, unlike an equal degree 
of depression induced by pentobarbital, was not reversed within 1 hour 
by replacing the bath solution with fresh Ringer’s solution. No spon- 
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taneity, missed beats, or contracture was evident even with severe myo- 
cardial depressant concentrations. 
Piminodine and Win 13,797 are myocardial depressants in the dog 
heart-lung perparation when sufficient drug is administered (Table 3). 
Slight depression at 100 pg/l, and severe depression at 1 mg/l, was ob- 
served for both compounds, employing the Slope method to determine 
TABLE 3 
COMPAFSSON OF TIXE DEPRESSANT EFFECTS OF PIMINODINE, WIN 13,797, AND 


























Control 100 100 100 1CKJ 100 100 
IOC 98 100 100 86 92 94 
100 96 100 9s 72 86 91 
1,000 92 100 98 41 49 74 
10,ocQ 22 46 9s 12 16 44 
20,000 0 0 81 <I <I 17 





b S = S control - S drug X 100 where S control z stroke volume/RAP during 
S control 
control and S drug Y stroke volume/RAP after drug administration. 
c Ten micrograms of drug was added after control period. Effect was determined 
after a 30-minute exposure. Concentration was then increased to 100 pg and effect 
determined after an additional 30-minute exposure. Concentration then increased to 
1000 ug, etc. All drug solutions were prepared in 10% propylene glycol and saline. 
cardiac function. If cardiac function is determined by the Competence 
Index method, the same qualitative results apply; however, severe 
myocardial depression is not noted until concentrations of IO mg/l are 
attained. As was noted in the cat papillary muscle, piminodine is more 
of a depressant than Win 13,797, but again both compounds were more 
depressant than meperidine on an equimolar basis. As expected from 
initial results in the papillary muscle preparations, nalorphine, 2 mg/l, was 
ineffective in antagonizing the cardiac depression produced in the heart- 
lung preparation by the two agents at 10 mg/l. However, ouabain, 100 
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pg/l, was quite effective in reversing the depression produced by either 
piminodine or Win 13,797 at 10 mg/l. 
Piminodine is somewhat more a cardiac depressant than Win 13,797. 
This difference cannot be explained on a greater penetration of piminodine 
into cardiac muscle in light of distribution studies carried out in this 
study. In any event, the doses of either agent required for moderate 
cardiac depression are much greater than doses necessary to obtain central 
nervous system activity. Both compounds were more potent than meperi- 
dine as cardiac depressants on an equimolar basis. However, the ratio 
of analgetic activity to cardiac depressant activity of these compounds 
compared to meperidine would appear to be approximately the same. 
Gastrointestinal Actions-Isolated Rabbit Jejunal Segment 
Piminodine, Win 13,797, and meperidine were studied with respect to 
a comparison of their effects on the isolated rabbit jejunal segment. No 
effect was observed with any of the three compounds at concentrations of 
10 ug per liter of Tyrode’s solution. Approximately an 80% decrease in 
the average amplitude of contraction was observed after a 30-minute 
exposure to 1 mg/l piminodine in Tyrode’s solution. At 5 mg/l, either 
piminodine or Win 13,797 caused an almost complete suppression of 
amplitude of contraction after a lo-minute exposure whereas meperidine 
produced a 60-70s depression of amplitude at this concentration after a 
30-minute exposure. Thus, Win 13,797 was less effective than piminodine, 
but both these compounds were more effective than meperidine, which 
parallels the results obtained with cardiac muscle. The frequency of con- 
tractions was not altered by any of these three agents, even when the 
average amplitude of contraction was markedly depressed. In addition, 
all three agents caused an equal degree of relaxation of tonus. Nalorphine, 
2 mg/l of Tyrode’s solution, was ineffective in reversing the depression 
due to 5 mg/l of piminodine or Win 13,797. 
Thus, the actions of piminodine, Win 13,797, on isolated jejunal seg- 
ments were qualitatively the same as those obtained with meperidine, viz., 
a decrease in amplitude of contraction and increase in resting length of 
the strip. Such activity would not be anticipated with doses required for 
desired central nervous system activity. 
EEG Efiects in Dogs with Chronically Implant’ed Electrodes 
In general, the gross behavioral and EEG phenomena following the 
intravenous administration of piminodine, Win 13,797, and morphine 
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paralleled one another. After drug injection the animals appeared less 
agitated in the testing apparatus and showed motor weakness, especially 
of the hindquarters. The animals frequently had to be supported in the 
recording apparatus. The well-known signs of morphinelike action were 
present, including dulling of awareness, marked salivation, and defecation. 
These effects became maximal in approximately 15-30 minutes after the 
injection of each drug. At the height of the actions of morphine the EEG 
showed generalized high voltage slow waves in both the cortical and sub- 
cortical structures. However, EEG arousal with peripheral afferent stimu- 
lation was easily obtained. Electrical activity in the olfactory bulb was 
decreased paralleling a decrease in the depth of respiration. The ad- 
ministration of 1 mg/kg of nalorphine promptly reversed the gross be- 
havioral and the EEG effects of morphine. Characteristically the electrical 
activity of the olfactory bulb and amygdala were very much enhanced 
after the administration of nalorphine to the narcotized dogs. The ad- 
ministration of nalorphine alone to normal dogs in comparable doses did 
not produce such enhanced activity. 
The actions of piminodine were qualitatively similar but definitely 
much weaker than morphine, both behaviorally and electroencephalo- 
graphically. The EEG effects of this agent are illustrated in Fig. 3. The 
control activity for the various brain areas is fairly typical, as can be 
observed in panel A. In the neocortical areas as well as in the dorsal 
hypothalamus and mesencephalic reticular formation generally low voltage, 
fast frequency activity was seen. The activity of the olfactory bulb and 
medial amygdala consisted of periodic bursts of high frequency waves that 
were generally synchronous with respiration. Blockade of the ipsilateral 
nostril prevented this burst activity from appearing in both the amygdala 
and the olfactory bulb. After administration of 1 mg/kg of piminodine 
some slow waves were observed in both the neocortical areas. Respiratory 
depth was not particularly affected. Frequently panting was noted and 
some olfactory bulb activity was still present as illustrated in panel B, 
Fig. 3. As in the case of morphine, the injection of nalorphine promptly 
restored the low voltage, fast frequency cortical EEG activity to normal 
while the discharges in the amygdala were enhanced (see panel C, 
Fig. 3). 
The actions of Win 13,797 were qualitatively and quantitatively similar 
to those of morphine. 
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FIG. 3. EEG effects of piminodine. Bipolar recordings were taken throughout: 
A8, cortical area 8; Ala, anterior portion of cortical area 1; Alp, posterior portion of 
cortical area 1; DH, dorsal hypothalamus; MR, mesencephalic reticular formation; 
Amg, medial amygdafa; Resp, thoracic respiration; inspiration is down, expiration is 
up; OB, olfactory bulb. Panel A, control, Panel B, 15 minutes after the intravenous 
administration of I mg/kg of piminodine. Panel C, 1 minute after the intravenous 
administration of I mg/kg of nalorphine hydrochloride. 
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Tolerance and Addiction 
Monkey. (a) Single-dose suppression. Figure 4 represents the results 
of the single-dose suppression studies with placebo, 3 mg/kg morphine 
sulfate, 0.1 mg/kg piminodine, and 0.05 mg/kg Win 13,797. Each point 
on each curve represents the average grade of the group of 5 monkeys. 
Taking into account the difference in the preinjection grades, each of the 
three drugs suppressed morphine abstinence signs to approximately the 
, 
I I t , ! 
, 
I 2 3 4 5 6 
HOURS AFTER ADMINISTRATION 
FIG. 4. Effect of piminodine and Win 13,797 on single-dose suppression studies 
in monkeys showing abstinence signs of intermediate intensity. 
same degree. The duration of action of piminodine was less than that of 
Win 13,797, which was less than that of morphine (duration measured as 
the time required for the monkeys to return to the preinjection level of 
excitability). The results of other doses tested by this technique are 
summarized in Table 4. 
The single-dose suppression studies indicated that both piminodine and 
Win 13,797 possess morphinelike physical dependence capacity in the 
rhesus monkey. The former is approximately 30 times as potent as 
morphine in this respect, and the latter about 60 times as potent as 
morphine. The effects of single doses of these drugs in nontolerant mon- 
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keys confirmed this high order of potency of these drugs relative to 
morphine in this species8 
(b) Primary physical dependence to Win 13,797. Stupor of inter- 
mediate (grade 4) degree was produced by the initial dose (0.1 mg/kg) 
of Win 13,797, but no cumulative effects resulted upon repeated adminis- 
tration. After each increment in dosage, effects at least as intense as 
those of the initial dose reappeared. The only evidence of tolerance 
development to 3 mg/kg was a slight decrease in the duration of action. 
TABLE 4 
SUMMARY OF SINGLE-DOSE SUPPRESSION STUDIES IN THE MONKEY AFTER 
SUBCUTANEOUS INJECTION OF PLACEBO, PIM~NO~N~, WIN 13,797, 
AND MORPHINE 
Time of 
Maximum peak Duration 
Dose suppression effect of action 
Drug Ow/k) (grades) (hours) (hours) 
NaCl 4.5a - - - 
Morphine 
sulfate 3.oa 4.2 2 6 
Piminodine 0.1a 3,s 1 3.7 
0.2 4.2 s and 1 4.7 
0.4 7.6 s and 1 6 
Win 13,797 0.05a 4.a 1 5 
0.1 6.0 % 5 
0.2 6.8 % 5.7 
a These data are graphically represented in Fig. 4. 
No anorexia resulted when the dose was raised to 2 and 3 mg/kg. One 
of the monkeys was found dead on the morning of the 117th day, but the 
cause of death was not apparent at autopsy. 
Severe withdrawal signs (grade 7) appeared in all three monkeys and 
persisted at peak severity for 3 hours after nalorphine administration on 
the 36th day. A 36-hour abrupt withdrawal was conducted in the 125th 
e These data were obtained by a double-blind technique in a program of evaluat- 
ing physical dependence liability sponsored by the Committee on Drug Addiction and 
Narcotics of the National Research Council. Dr. N. B. Eddy, Secretary, supplied 
the drugs among a series of coded unknowns. The data were confirmed in subse- 
quent repetition of the experiments in which the identities of the compounds were 
known. 
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day to determine the rate of onset of abstinence signs. Signs began to 
appear at the 7th hour of withdrawal, but the intensification was relatively 
slow. At the 36th hour signs were of mild intensity (grade 2) in one 
monkey and intermediate (grade 4) in the other. Chronic treatment with 
3 mg/kg Win 13,797 was then reinstituted, and neither monkey showed 
any evidence of loss of tolerance over the 36-hour period of withdrawal. 
Both monkeys showed mild gastrointestinal signs, severe dyspnea, 
severe muscular weakness, and prostration within 5 minutes of the injection 
of nalorphine on the 146th day of treatment. Ten minutes after injection 
both monkeys had brief (30-60 seconds) tonic seizures. Each monkey had 
several seizures over a H-minute period after which it lay quietly. Muscu- 
lar weakness was of such severity that the monkeys could not maintain 
the sitting posture. One and one half hours after injection of nalorphine, 
muscular strength began to return and extreme motor restlessness persisted 
for s hour. The two monkeys began to fight and this precipitated a 
prolonged seizure in one animal which expired before the seizure could 
be antidoted. The second monkey then began to scream and to circle, 
collapsed, and died of respiratory failure. The primary physical de- 
pendence study with Win 13,797 confirmed the fact that this agent is 
very potent in the monkey and that it possesses morphinelike physical 
dependence capacity. 
Dog-p&nary physical dependence. Initial doses of morphine, pimino- 
dine, and Win 13,797 produced salivation, retching, defecation, and seda- 
tion in all dogs. Vomiting was produced only in those dogs which re- 
ceived Win 13,797, and cumulative depression was observed only with 
this drug. Tolerance to the sedative effects developed within 2-6 days, 
but tolerance development to the gastrointestinal effects was minimal. 
Narcotic abstinence signs observed in dogs included nausea, retching, 
vomiting, diarrhea, coughing, piloerection, shivering, hyperpnea, dyspnea, 
restlessness, growling, fighting, howling, apprehension toward the observer, 
muscular tenderness, muscular tremors, “digging,” and signs of sexual 
excitation. The withdrawal intensities are summarized in Table 5. 
Compared to morphine, the piminodine withdrawals were characterized 
by milder muscular signs and more severe gastrointestinal signs. Sexual 
signs, gastrointestinal signs, and muscular tremors were the most prominent 
features of withdrawal from Win 13,797. 
These studies in the dog also demonstrated that piminodine and Win 
13,797 produce morphinelike effects in nontolerant animals and have the 
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capacity to induce morphinelike physical dependence. The dog, however, 
is relatively much less sensitive to these compounds than the monkey. On 
the basis of acute effects in nontolerant dogs and the intensities of the 
abstinence syndromes in physically dependent dogs the relative potencies 
of the drugs studied were: morphine sulfate, 1.0; Win 13,797, 1.0; 
TABLE 5 












sulfate 26 1.0 Nalorphine-induced 3.0 
45 2.0 Nalorphine-induced 3.8 
65 3.0 Nalorphine-induced 4.3 
69 3.0 Abrupt 3.oa 
26 2.0 Nalorphine-induced 2.8 
45 4.0 Nalorphine-induced 4.8 
65 6.0 Nalorphine-induced 5.8 
69 6.0 Abrupt 3.ob 
Win 13,797 26 I.0 Nalorphine-induced 2.3 
45 2.0 Nalorphine-induced 3.7 
65 3.0 Nalorphine-induced 4.8 
69 3.0 Abrupt 3.oc 
a Onset of signs was at 8 hours, peak intensity at 30 hours; duration of withdrawal 
was 8 days. 
b Onset of signs was at 10 hours, peak intensity 12 through 72 hours; duration of 
withdrawal was 10 days, 
C Onset of signs was at 10 hours, peak intensity 36 through 60 hours; duration of 
withdrawal was 9 days. 
piminodine, 0.5. The relative sensitivity of the dog to these compounds 
thus parallels that of the rat and man. The reason why the monkey should 
be so sensitive to these particular piperidine derivatives remains obscure. 
While this quantitative discrepancy serves to caution against the direct 
extrapolation of data regarding narcotic analgesics from monkey to man, 
it does not affect the superior usefulness of the monkey for the qualitative 
evaluation of this class of drugs. 
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Physiological Disposition 
Plasma .lev,els and &vaary excretion. Two female mongrel dogs were 
injected subcutaneously with a dose of 6.5 mg/kg for each drug, pimino- 
dine and Win 13,797. The concentration in plasma fell within the area 
of lowest sensitivity of the method, and accordingly, the values were 
somewhat erratic. Levels never exceed 0.3 u (free base) per milliliter of 
plasma, and generally the maximum value occurred 60-90 minutes after 
administration. The two dogs injected with piminodine eliminated in the 
urine 1.4 and 2.4% of the administered dose, respectively. Both dogs 
receiving Win 13,797 excreted less than 1% of the administered dose. 
It is obvious from these data on plasma levels and urinary excretion 
that the major portion of each of these drugs is metabolized, probably 
by hydrolysis of the ester configuration. 
TABLE 6 
CONCENTRATIONS OF PIMINODINE AND WIN 13,797 IN NONTOLERANT AND TOLERANT 
DOGS 90 MINUTES AFTER THE SUBCUTANEOUS INJECTION OF 6,~ MG/KG OF DRUG 











Piminodinec Win 13,797-3C Piminodine Win l3,797C 
13, 13 11, 9 17 7.7, 9.2 
8.9, 8.4 6.6, 6.1 8.2 -, 2.2 
7.3, 7.9 6.3, 5 - -> - 
5.5, 5.2 5.5, 5.4 5 - 
5.8, 5.4 5, 5 5 8;: 5 
5, 5 5, 5 6.2 5, 5.1 
5.5, 5.4 5.7, 5 6.9 5.4, 6.9 
5.5, 5.4 5, 5 5 5, 5 
Trace Trace, 0.2 - -7 - 
a Concentration in micrograms (free base) per milliliter or gram. 
b Duodenum and omental fat were analyzed for the respective drug in each of the 
animals. The drug levels were less than 5 ug/g except for the value of 9.3 kg/g for 
Win 13,797 for one tolerant dog. 
c Each figure represents one animal and is the mean value of duplicate determina- 
tions performed on the tissue or fluid removed from one dog. 
Tissue distributiofi in %ontolerant and tolerant dogs. These data are 
summarized in Table 6. In the nontolerant dog the highest concentrations 
are found in bile. The concentration of both drugs in brain after the 
administration of 6.5 mg/kg is about 5 ug (free base) per gram. Fat 
(omental) was very low 90 minutes after administration of the drug, sug- 
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gesting minimal solubility of these drugs in neutral fat. In general there 
was no significant difference between the nontolerant and tolerant animals. 
SUMMARY 
The toxic and lethal effects of piminodine and Win 13,797 were studied in mice, 
dogs, and monkeys. The analgesic actions of both drugs were tested in mice and 
rats and were found to be more potent than morphine, 
Vascular studies on pimincdine and Win 13,797 have shown peripheral vasodilation 
and acute vascular tolerance to the hypotensive effect in dogs with partial crossed 
tolerance to morphine. Dogs anesthetized with pentobarbital were sensitive to the 
respiratory depressant actions of these drugs. Nalorphine readily antagonizes this 
respiratory depression. 
Piminodine and Win 13,797 are myocardial depressants on the dog heart-lung prepa- 
ration and the cat papillary muscle, but on!y in doses or concentrations much higher 
than would be used therapeutically. 
The actions of piminodine and Win 13,797 on the isolated rabbit jejunal segment 
are minimal. 
The qualitative actions of pimincdine and Win 13,797 on EEG effects in dogs 
with chronically implanted electrodes were like those of morphine. Quantitatively, 
Win 13,797 was equipotent to morphine, and piminodine one-half as effective. 
Studies on single-dose suppression in monkey and primary physical dependence in 
dogs and monkeys indicate that piminodine and Win 13,797 have high addiction 
liability at least in these species. 
Nearly all the administered piminodine or Win 13,797 is altered chemically when 
injected into dogs. There is no evidence for marked local tissue deposition for either 
drug. 
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